Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel diseaseBindia Jharap, Nanne K.H. de Boer, Pieter Stokkers et al.|Gut|2013Cited by 144
Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver AgreementBindia Jharap, Dirk P. van Asseldonk, Nanne K.H. de Boer et al.|PLoS ONE|2015Cited by 60
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry StudyTessa Straatmijer, Joep Grootjans, Fiona D.M. van Schaik et al.|Clinical Gastroenterology and Hepatology|2022Cited by 51
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trialReinier C A van Linschoten, Aura A. J. van Esch, Fenna M. Jansen et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 21
A Systematic Review on Long-Term Efficacy Outcome Measures in Crohn’s Disease PatientsLaura Janssen, Marieke Pierik, Rob H. Creemers et al.|Journal of Crohn s and Colitis|2023Cited by 14